Welcome to LookChem.com Sign In|Join Free

CAS

  • or

53750-66-6

Post Buying Request

53750-66-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

53750-66-6 Usage

General Description

4-Chloro-pyridine-2-carbonyl chloride is a chemical compound that is commonly used in organic synthesis and pharmaceutical research. It is a chlorinated derivative of pyridine, which is a heterocyclic aromatic compound. The carbonyl chloride group makes this compound reactive and useful as a building block for creating various organic compounds. It is often used as an intermediate in the manufacturing of pharmaceuticals and agrochemicals. This chemical has a wide range of applications in the research and development of new drugs and agricultural products. However, it is important to handle 4-Chloro-pyridine-2-carbonyl chloride with care due to its reactivity and potential hazards.

Check Digit Verification of cas no

The CAS Registry Mumber 53750-66-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,7,5 and 0 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 53750-66:
(7*5)+(6*3)+(5*7)+(4*5)+(3*0)+(2*6)+(1*6)=126
126 % 10 = 6
So 53750-66-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H3Cl2NO/c7-4-1-2-9-5(3-4)6(8)10/h1-3H

53750-66-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Chloro-pyridine-2-carbonyl chloride

1.2 Other means of identification

Product number -
Other names 4-chloropicolinoyl chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:53750-66-6 SDS

53750-66-6Relevant articles and documents

METHODS OF USING REBASTINIB IN THE TREATMENT OF DISORDERS

-

Paragraph 0467, (2021/09/10)

Described herein are methods of treating various disorders in patients in need thereof, comprising administering to the patient the compound of Formula (I) or a pharmaceutically acceptable salt thereof. Exemplary disorders that can be treated by the methods described herein include gynecologic carcinosarcomas, endometrial adenocarcinomas, mesotheliomas, ovarian cancers, pancreatic ductal adenocarcinomas, and lung cancers.

Synthesis of N-trifluoromethyl amides from carboxylic acids

Flavell, Robert R.,Liu, Jianbo,Parker, Matthew F. L.,Toste, F. Dean,Wang, Sinan,Wilson, David M.

supporting information, p. 2245 - 2255 (2021/08/12)

Found in biomolecules, pharmaceuticals, and agrochemicals, amide-containing molecules are ubiquitous in nature, and their derivatization represents a significant methodological goal in fluorine chemistry. Trifluoromethyl amides have emerged as important functional groups frequently found in pharmaceutical compounds. To date, there is no strategy for synthesizing N-trifluoromethyl amides from abundant organic carboxylic acid derivatives, which are ideal starting materials in amide synthesis. Here, we report the synthesis of N-trifluoromethyl amides from carboxylic acid halides and esters under mild conditions via isothiocyanates in the presence of silver fluoride at room temperature. Through this strategy, isothiocyanates are desulfurized with AgF, and then the formed derivative is acylated to afford N-trifluoromethyl amides, including previously inaccessible structures. This method shows broad scope, provides a platform for rapidly generating N-trifluoromethyl amides by virtue of the diversity and availability of both reaction partners, and should find application in the modification of advanced intermediates.

Synthesis and evaluation of new thiourea derivatives as antitumor and antiangiogenic agents

Bai, Wenjing,Huang, Qiang,Ji, Jianxin,Wei, Wei

supporting information, (2020/09/07)

A series of novel thiourea derivatives were synthesized and evaluated by biological activities. Among them, compound 10e containing 3,5-bis(trifluoromethyl)phenyl moiety (R1) at the terminal thiourea and phenylamino (R2) at the terminal acyl position showed the best cytotoxic activities against seven cancer cell lines (NCI-H460, Colo-205, HCT116, MDA-MB-231, MCF-7, HepG2, PLC/PRF/5) and HUVECs. Moreover, compound 10e moderately inhibited various RTKs such as VEGFR2, VEGFR3, and PDGFRβ. Notably, 10e exhibited much better inhibitory effect of tumor formation and antiangiogenic activities than Sorafenib and Regorafenib at the same concentration. Further docking studies suggested that 10e could serve as potential candidate for cancer therapy.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 53750-66-6